Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Neuroeng Rehabil ; 19(1): 38, 2022 04 02.
Artículo en Inglés | MEDLINE | ID: mdl-35366930

RESUMEN

BACKGROUND: Advanced assistive technologies (AAT) aim to exploit the vast potential of technological developments made in the past decades to improve the quality of life of people with disabilities. Combining complex robotic technologies with the unique needs of people with disabilities requires a strong focus on user-centered design to ensure that the AAT appropriately addresses the daily life struggles of target users. The CYBATHLON aims to promote this mindset by empowering the AAT target users ("pilots") to compete on race tracks that represent approximations of daily life obstacles. The objective of this work was to investigate the AAT technology development, usability, and user involvement (i.e., application of user-centered design) in the context of the CYBATHLON. METHODS: With an online survey targeting the pilots and technical leads of teams preparing for the CYBATHLON 2020 Global Edition, we investigated to what extent the pilots were involved in device development and how this influences the perceived usability of the showcased AAT. Furthermore, the effects of user-centered design variables on the individual race performances were analyzed. RESULTS: A total of 81 responses from 35 pilots and 46 technical leads were collected in the two weeks prior to the event. Of all teams partaking in the included disciplines of the CYBATHLON 2020 Global Edition, 81.8% (36 of 44) were included in the study. User-centered design appeared to be a prevalent practice among the teams, as 85.7% of all pilots reported a certain level of involvement. However, only 25.5% of the pilots reported daily life usage, despite QUEST usability scores of both respondent groups showing moderate to high satisfaction with the respected AAT across all investigated disciplines. An explorative linear mixed model indicated that daily life usage (p < 0.05) and prolonged user involvement (e.g., more than 2 years, p < 0.001) have a significant positive effect on the race performance at the competition. CONCLUSIONS: We conclude that the CYBATHLON positively fulfills its conceptual goals of promoting active participation and inclusion of people with disabilities in the design and evaluation of AAT, thereby stimulating the development of promising novel technological solutions. Also, our data could underline the value of the competition as a benchmark, highlighting remaining usability limitations or technology adoption hurdles.


Asunto(s)
Personas con Discapacidad , Robótica , Dispositivos de Autoayuda , Humanos , Calidad de Vida , Encuestas y Cuestionarios
2.
Environ Sci Technol ; 52(18): 10864-10873, 2018 09 18.
Artículo en Inglés | MEDLINE | ID: mdl-30132664

RESUMEN

Batteries are one of the key technologies for flexible energy systems in the future. In particular, vanadium redox flow batteries (VRFB) are well suited to provide modular and scalable energy storage due to favorable characteristics such as long cycle life, easy scale-up, and good recyclability. However, there is a lack of detailed original studies on the potential environmental impacts of their production and operation. The present study fills this gap by providing a comprehensive life cycle assessment of a representative VRFB. Transparent and comprehensive inventory data are disclosed as a basis for further environmental studies. VRFBs are found to be promising regarding the assessed impact categories, especially at high energy-to-power (E/P) ratios. On the other hand, significant impacts are associated with the vanadium pentoxide production, which is why the origin and processing of the vanadium bearing ores are a key for further reducing the environmental impacts associated with the VRFB manufacturing. While the lower efficiency of the VRFB is a disadvantage in comparison to e.g. lithium-ion batteries (LIB), its recyclability is significantly higher. In this sense, the importance of taking a cradle-to-cradle life cycle perspective when comparing very different battery systems can be highlighted for further research on this topic.


Asunto(s)
Suministros de Energía Eléctrica , Vanadio , Iones , Litio , Oxidación-Reducción
3.
Front Cardiovasc Med ; 9: 951042, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36247452

RESUMEN

Background: Tailored recommendations for patients after percutaneous coronary interventions (PCI) need physical activity (PA) to be objectively measured and assessed for adherence to guidelines. The recent WHO guidelines removed the daily recommended bout duration, while the potential impact of this change on patients after PCI remains unclear. Aim: We evaluated prevalence estimates of adherence to PA recommendations among patients after PCI across the 2010 [≥30 min moderate- to vigorous-intensity PA (MVPA) at ≥ 10-min bout duration] and 2020 WHO guidelines (≥30 min of MVPA of any bout duration), as well as 7,500 and 10,000 steps. Methods: We conducted an observational longitudinal single-center study with patients after PCI for chronic or acute coronary syndrome (ACS); maximal age 80 years. Wrist-worn accelerometers recorded participants' PA data from the evening of hospital discharge over the next 18 days. Results: We analyzed data from 282 participants with sufficient minimum wear time (7 days of ≥12 h), including 45 (16%) women; and 249 (88%) with ACS. Median wear time was 18 (17, 18) days. Median participant age was 62 (55, 69) years. Fifty-two participants (18.4%) fulfilled 2010 WHO guidelines and 226 (80.1%) fulfilled the 2020 WHO guidelines. Further, 209 (74.1%) participants achieved ≥7,500 steps/day and 155 (55.0%) performed ≥10,000 steps/day. Conclusion: Among participants after PCI, most MVPA was accumulated in bouts <10 min, leading to a fourfold discrepancy between participants fulfilling the 2010 and 2020 WHO PA recommendations. The number of steps/day may be a valid proxy to recent WHO PA recommendations as it is not dependent on the bout-length definition. Clinical trial registration: [ClinicalTrials.gov], identifier [NCT04663373].

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA